Home › NDC Lookup › Ingredients › Polyvinyl Alcohol And Povidone › 67172-0181-01
👁️image loading
(from DailyMed)

Artificial Tears Lubricant Eye Polyvinyl Alcohol and Povidone 5 mg/mL; 6 mg/mL Liquid — NDC 67172-181-01 (Billing 67172-0181-01)

by Prestige Brands Holdings, Inc. · 1 BOTTLE, DROPPER in 1 BOX / 15 mL in 1 BOTTLE, DROPPER

This is a package of Artificial Tears Lubricant Eye Polyvinyl Alcohol and Povidone 5 mg/mL; 6 mg/mL Liquid from Prestige Brands Holdings, Inc., no longer marketed (first marketed Jun 2012), no longer in the FDA NDC Directory. It is this product's only package size.

NDC 67172-0181-01
🏷️ FDA NDC (as labeled) 67172-181-01 billing pads the product segment with a zero
OTC Discontinued Non-controlled ⚠ Discontinued by firm ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

⚠️
Excluded from the active FDA NDC Directory. The labeler reported this product as discontinued, so it is excluded from the active NDC Directory. The listing was last certified through Jul 2025. A label may still appear on DailyMed, but the NDC is no longer in the current FDA NDC Directory. Search the FDA NDC Directory ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 67172-181-01
Product NDC 67172-181
11-digit billing NDC 67172018101
RxCUI 598050
UNII 532B59J990, FZ989GH94E
Application # M018
SPL Set ID 4cee7eba-8338-42c5-92ca-71c7df1bbf04
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status Discontinued
FDA listing status Discontinued by firm (certified through Jul 2025)
Marketing start 2012-06-01
Route OPHTHALMIC
Dosage form LIQUID
Substance POLYVINYL ALCOHOL, UNSPECIFIED; POVIDONE
Quick answers
  • RxCUI (RxNorm): 598050
Why two NDCs? The FDA registers this code as 67172-181-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 67172-0181-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

🧪 What is this product?

This is an over-the-counter eye lubricant liquid containing polyvinyl alcohol and povidone. These ingredients function as lubricants and are commonly used to temporarily soothe and moisten dry eyes. The product is applied directly to the eye surface and is marketed as an OTC monograph drug, meaning it follows FDA's established safety and use guidelines for this category of eye lubricants rather than being individually approved through a separate application process.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
67172-0181-01 You're viewing this Main listing 1 BOTTLE, DROPPER in 1 BOX / 15 mL in 1 BOTTLE, DROPPER 2012-06-01 — Discontinued by firm

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Good Neighbor Pharmacy Artifical Tears Lubricant Eye Drops .5 g/100mL; .6 g/100mL 24385-0006-05 AmerisourceBergen 1 bottle $0.113 — Availability likely —
Leader Artificial Tears 15 mL .5 g/100mL; .6 g/100mL 70000-0011-01 Cardinal 1 bottle $0.113 — Availability likely —
Quality Choice Artificial Tears Lubricant Eye Drops .5 g/100mL; .6 g/100mL 83324-0189-14 Chain 1 bottle $0.113 — Availability likely —
Walgreens Soothing Eye Relief Lubricant Eye Drops .5 g/100mL; .6 g/100mL 00363-0796-01 Walgreens 1 bottle — — FDA listed —
Topcare Health Artificial Tears .5 g/100mL; .6 g/100mL 36800-0972-01 Topco 1 bottle — — FDA listed —
Meijer Artificial Tears .6 g/100mL; .5 g/100mL 41250-0819-01 Meijer 1 bottle — — FDA listed —
Good Sense Artificial Tears .5 g/100mL; .6 g/100mL 50804-0110-01 Geiss, 1 bottle — — FDA listed —
Family Wellness Artificial Tears .6 g/100mL; .5 g/100mL 55319-0908-01 Family 1 bottle — — FDA listed —
Artificial Tears 6 mg/mL; 5 mg/mL 55651-0008-01 KC 1 bottle — — FDA listed —
Publix Artificial Tears Eye Drops 500 mg/100mL; 600 mg/100mL 56062-0666-01 Publix 1 bottle — — FDA listed —
Kroger Eye Drops Artificial Tears .6 g/100mL; .5 g/100mL 59450-0814-01 The 1 bottle — — FDA listed —
Stye 5 mg/mL; 6 mg/mL 63029-0324-15 Medtech 1 bottle — — FDA listed —
Goodsense Artificial Tears 5 mg/mL; 6 mg/mL 63187-0298-15 Proficient 1 bottle — — FDA listed —
GoodSense Artifical Tears .05 g/mL; .06 g/mL 63187-0893-15 Proficient 1 bottle — — FDA listed —
Best Choice Artificial Tears .5 g/100mL; .6 g/100mL 63941-0015-01 Best 1 bottle — — FDA listed —
Artificial Tears Lubricant Eye 5 mg/mL; 6 mg/mLthis 67172-0181-01 Prestige 1 bottle — — Discontinued —
Clear Eyes Natural Tears 5 mg/mL; 6 mg/mL 67172-0557-02 Prestige 1 bottle — — FDA listed —
Artificial Tears .5 g/100mL; .6 g/100mL 68071-4914-05 NuCare 15 ml — — FDA listed —
Good Neighbor Pharmacy Artifical Tears Lubricant Eye Drops .5 g/100mL; .6 g/100mL 71205-0134-15 Proficient 15 ml — — FDA listed —
CareOne Artificial Tears Eye Drops 15mL .5 g/100mL; .6 g/100mL 72476-0038-01 Retail 1 bottle — — FDA listed —
Equate Artificial Tears .6 g/100mL; .5 g/100mL 79903-0157-05 Walmart, 1 bottle — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2012
On the market since
Jun 2012
📍
2026
Currently FDA-listed
14 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerPrestige Brands Holdings, Inc.
FDA applicationM018 (OTC MONOGRAPH DRUG)
Labeler code67172
First marketedJun 2012
Product typeHuman Otc Drug
Portfolio42 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose
🎯 Indications and Usage 30 words ▾

Uses For the temporary relief of burning & irritations due to dryness of the eye. For use as a protectant against further irritation or to relieve dryness of the eye.

⏱️ Dosage and Administration 12 words ▾

Directions Instill 1 to 2 drops in the affected eye(s) as needed.

⚠️ Warnings 87 words ▾

Warnings For external use only Do not use if solution changes color or becomes cloudy. When using this product: to avoid contamination, do not touch tip to any surface. replace cap after using. Stop use and ask a doctor if: you experience eye pain you experience changes in vision you experience continued redness or irritation of the eye the condition worsens symptoms last for more than 72 hours Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

🧪 Active Ingredient 7 words ▾

Active ingredients Polyvinyl alcohol 0.5% Povidone 0.6%

🧪 Inactive Ingredients 22 words ▾

Inactive ingredients benzalkonium chloride, dextrose, edetate disodium, potassium chloride, purified water, sodium bicarbonate, sodium chloride, sodium citrate, sodium phosphate (mono- and dibasic)

🎯 Purpose 2 words ▾

Purpose Lubricant

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Artificial Tears Lubricant Eye (this brand).

Top reported reactions

Blood Triglycerides Increased1
Burkholderia Test Positive1
Covid-191
Dyspnoea1
Endotracheal Intubation1
Pyrexia1
Respiratory Rate Decreased1

Reporter sex

0 reports
Male · 33%
Female · 33%
Unknown · 33%

Serious outcomes

Hospitalization2
Reports over time (by year) — tap or hover for the count & year
2022 2023 2024 2026 1 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product No longer marketed (per FDA listing data)
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
What does the discontinued status mean for this NDC?
The labeler reported a marketing end date (or the listing was delisted), so this specific package is no longer actively marketed. Remaining stock may still be dispensed for a time, and the NDC stays valid for historical records and claims — but data feeds (pricing, labeling) typically stop updating for it. Other package sizes or other manufacturers' versions of the same medication may still be marketed — see the equivalents section where available.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Who lists this product with the FDA?
Prestige Brands Holdings, Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 67172-0150-06 · Prestige 67172-0212-31 · Prestige →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.